Therapeutic solutions ensure good control of cardiovascular diseases and increase patients’ quality of life   According to the data of the National Health Insurance Fund for the third quarter of the last year, Tchaikapharma’s medicinal product “Zornichka” with active ingredient (INN) chlorthalidone marked an increase in the number of packages sold by nearly 95% (compared […]

Once again, Tchaikapharma High Quality Medicines participated in the National Conference on Hospital Pharmacy held in Sofia from 18-20 October 2024. The leading Bulgarian manufacturer of complex generics (polypills) presented its new products for the treatment of socially significant diseases such as cerebrovascular disease, Parkinson’s disease, impaired metabolic syndrome, angina pectoris, arterial hypertension and heart […]

Tchaikapharma has received marketing authorization for a new medicinal product:   Telmira 60 mg film-coated tablets Telmira 90 mg film-coated tablets   Telmira contains a medicinal substance called ticagrelor. It belongs to a group of medicines called antithrombotic medicines.   Telmira, given at the same time as acetylsalicylic acid (ASA), is indicated for the prevention […]

The latest medicinal product to receive Marketing Authorisation from the Bulgarian Drug Agency is:   Ferbessa 4 mg/5 mg tablets   Ferbessa 8 mg/5 mg tablets   Ferbessa is a combination of the two active substances: perindopril and amlodipine. Perindopril is an angiotensin-converting enzyme inhibitor (ACE inhibitor). Amlodipine is a calcium antagonist that belongs to […]

mag. pharma. Silvia Patrikova, Director of ‘Pharmaceutical Care’ and Member of the Board of Directors of Tchaikapharma High Quality Medicines   Nearly two years after the peak of the COVID-19 pandemic, the global pharmaceutical market is suffering from chaos in supply chains and unpredictable dynamics in demand for individual products. It is difficult to guarantee […]